China’s Drug Approval Processes Unchanged In SFDA-CFDA Transition
This article was originally published in PharmAsia News
Executive Summary
The China Food and Drug Administration announced that during its transition of duties from the State and Food Administration, all procedures and policies will remain unchanged.